Subscribe to RSS

DOI: 10.1055/s-0045-1814733
Scalable 68Ga Cold Kit Radiolabeling: High-Throughput Preparation of [68Ga]Ga-Edotreotide via Aliquoting and Dual Generator Strategy
Authors
Abstract
Objectives
The aim of the study was to develop and assess alternative radiolabeling strategies for SOMAKIT-TOC using gallium-68, with the aim of improving cost-efficiency by increasing the number of examinations per cold kit while maintaining radiochemical quality suitable for clinical use.
Materials and Methods
Four protocols were evaluated using triplicate test radiolabelings: (1) the reference method using a single generator and a full kit; (2) dual-generator elution into a full kit; (3) single-generator elution into two sequentially radiolabeled aliquots from one kit; and (4) dual-generator elution into two sequentially radiolabeled aliquots from one kit. Radiochemical purity (RCP) was assessed by radio-thin layer chromatography (rTLC) and radio-high performance liquid chromatography (rHPLC), and radiochemical stability was monitored over 4 hours. Additional quality controls parameters included pH, sterility, and peptide integrity in aliquot solution. Procedures 1 and 3 were further assessed in clinical routine.
Results
All protocols yielded radiopharmaceuticals with mean RCP values above 95% by rTLC. Procedure 2 significantly increased the final activity compared with Procedure 1. Procedure 3 enabled doubling the number of examinations per kit while maintaining RCP comparable to the reference method Procedure 4 showed greater variability. Radiolabeled products remained stable over 4 hours as assessed by rTLC, although rHPLC revealed a gradual decrease in purity. In clinical use, Procedure 3 allowed 94 preparations that met diagnostic needs, though 33% had RCP between 80 and 95%.
Conclusion
Aliquoting a single cold kit for dual radiolabeling using one generator is feasible and cost-effective, although it is associated with greater RCP variability. Dual-generator strategies yield higher activity but may further compromise RCP. Further optimization is required to improve robustness of off-label protocols while preserving the highest product quality.
Keywords
edotreotide - radiolabeling - gallium-68 - radiopharmaceuticals - PET imaging - neuroendocrine tumorsData Availability Statement
Data are available upon reasonable request.
Authors' Contributions
C.F. and L.R. conceptualized the manuscript. C.F. wrote and prepared the original draft and worked on the methodology. J.V., L.R., J.T., M.M.C., C.F. investigated the content. L.R., J.V., and S.C.R. wrote, reviewed, and edited the content. J.V., L.R., J.T., M.M.C., and C.F. visualized the manuscript. C.F. supervised the content. All authors have read and agreed to the published version of the manuscript.
Publication History
Article published online:
05 January 2026
© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Mukherjee A. An update on extemporaneous preparation of radiopharmaceuticals using freeze-dried cold kits. Mini Rev Med Chem 2021; 21 (11) 1322-1336
- 2 Satpati D. Recent breakthrough in 68Ga-radiopharmaceuticals cold kits for convenient PET radiopharmacy. Bioconjug Chem 2021; 32 (03) 430-447
- 3 Hennrich U, Benešová M. [68Ga]Ga-DOTA-TOC: the first FDA-approved 68Ga-radiopharmaceutical for PET imaging. Pharmaceuticals (Basel) 2020; 13 (03) 38
- 4 Bodei L, Ambrosini V, Herrmann K, Modlin I. Current concepts in 68Ga-DOTATATE imaging of neuroendocrine neoplasms: interpretation, biodistribution, dosimetry, and molecular strategies. J Nucl Med 2017; 58 (11) 1718-1726
- 5 Filippi L, Pizzichini P, Bagni O, Scopinaro F. Somatostatin receptor analogs (68Ga-DOTATOC, 68Ga-DOTANOC, 68Ga-DOTATATE). In: Calabria F, Schillaci O. eds. Radiopharmaceuticals. Cham: Springer Nature Switzerland; 2024: 105-119
- 6 Lepareur N. Cold kit labeling: the future of 68Ga radiopharmaceuticals?. Front Med (Lausanne) 2022; 9: 812050
- 7 European Directorate for the Quality of Medicines & Healthcare (EDQM). Gallium (68Ga) edotreotide injection. In: European Pharmacopoeia, 11th ed. Strasbourg, France: EDQM; 2022: 1274-1276 . Monograph No. 2482
- 8 European Directorate for the Quality of Medicines & Healthcare (EDQM). Gallium (68Ga) oxodotreotide injection. In: European Pharmacopoeia, 11th ed. (Ph. Eur. 11.0). Strasbourg, France: EDQM, Council of Europe; 2024: 5112-5113 . Monograph No. 3050
- 9 Kumar K. The current status of the production and supply of gallium-68. Cancer Biother Radiopharm 2020; 35 (03) 163-166
- 10 Asti M, Iori M, Capponi PC, Rubagotti S, Fraternali A, Versari A. Development of a simple kit-based method for preparation of pharmaceutical-grade 68Ga-DOTATOC. Nucl Med Commun 2015; 36 (05) 502-510
- 11 Meisenheimer M, Kürpig S, Essler M, Eppard E. Ethanol effects on 68Ga-radiolabelling efficacy and radiolysis in automated synthesis utilizing NaCl post-processing. EJNMMI Radiopharm Chem 2019; 4 (01) 26
- 12 Kleynhans J, Ebenhan T, Sathekge MM. Expanding role for gallium-68 PET imaging in oncology. Semin Nucl Med 2024; 54 (06) 778-791
- 13 Mueller D, Breeman WAP, Klette I. et al. Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution method. Nat Protoc 2016; 11 (06) 1057-1066
- 14 Manoharan P, Lamarca A, Navalkissoor S. et al. Safety, tolerability and clinical implementation of ‘ready-to-use’ 68gallium-DOTA0-Tyr3-octreotide (68Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs). ESMO Open 2020; 5 (02) e000650
- 15 Durieux F, Dekyndt B, Legrand JF. et al. Optimization of automated radiosynthesis of gallium-68-labeled PSMA11 with two [68Ge]Ge/[68Ga]Ga generators: fractional elution or prepurification?. Pharmaceuticals (Basel) 2023; 16 (11) 1544
- 16 van Brandwijk EA, Aalbersberg EA, Hosseini AS, Huitema ADR, Hendrikx JJMA. Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators. EJNMMI Radiopharm Chem 2024; 9 (01) 31
- 17 Penglis S, Tsopelas C. 99Tcm-tetrofosmin: evaluation of fractionated cold kits and two new methods of quality control. Nucl Med Commun 2000; 21 (05) 469-472
- 18 Negi M, Dhingra M, Dhingra VK. Quality of radiochemical purity in multiple samples of various fractionated cold kits: testing a cost & time effective technique. Hell J Nucl Med 2019; 22 (03) 200-205
- 19 Thokchom AK, Kumar R, Bharati S, Vasumathi. Quality assessment of Tc-99m methylene diphosphonate (MDP) radiopharmaceutical prepared using different cold kit fractionation methods. Indian J Nucl Med 2022; 37 (01) 7-11
- 20 Bhatia N, Vatsa R, Dhingra VK, Dhawan DK, Chadha VD. Evaluation of tetrofosmin cold kit fractionation using alternative new method of quality control for testing radiochemical purity. World J Nucl Med 2022; 21 (04) 314-319
- 21 Zulu JN, Katebe RN, Ramli MN. et al. Exploring the use of ambientally stored methylene diphosphonate radiopharmaceutical aliquots in solving challenging situations in developing countries. World J Nucl Med 2024; 23 (04) 264-269
- 22 Fang P, Jacobson MS, Hung JC. Influential factors in the preparation of 68Ga-DOTATATE. J Nucl Med Technol 2020; 48 (03) 263-268
- 23 Oehlke E, Le VS, Lengkeek N. et al. Influence of metal ions on the 68Ga-labeling of DOTATATE. Appl Radiat Isot 2013; 82: 232-238
- 24 Oehlke E, Lengkeek NA, So Le V, Pellegrini PA, Greguric I, Weiner R. The role of additives in moderating the influence of Fe(III) and Cu(II) on the radiochemical yield of [68Ga(DOTATATE)]. Appl Radiat Isot 2016; 107: 13-16
- 25 Breeman WAP, De Jong M, Visser TJ, Erion JL, Krenning EP. Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities. Eur J Nucl Med Mol Imaging 2003; 30 (06) 917-920
- 26 Prince D, Rossouw D, Rubow S. Optimization of a labeling and kit preparation method for Ga-68 Labeled DOTATATE, using cation exchange resin purified Ga-68 eluates obtained from a tin dioxide 68Ge/68Ga generator. Mol Imaging Biol 2018; 20 (06) 1008-1014
- 27 Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A. Development of single vial kits for preparation of (68)Ga-labelled peptides for PET imaging of neuroendocrine tumours. Mol Imaging Biol 2014; 16 (04) 550-557
- 28 Pandey U, Korde A, Mukherjee A. et al. Clinical experience with indigenous kit-based preparation of 68Ga-DOTATOC using commercial 68Ge/68Ga generator. Appl Radiat Isot 2018; 136: 59-64
- 29 Panagiotidis E, Andreou S, Vatalis A. et al. Radiochemical purity and patient preparation: key factors affecting the accuracy of 68Ga-DOTATOC PET/CT imaging in neuroendocrine tumors. Hell J Nucl Med 2024; 27 (03) 236-242
- 30 Nelson BJB, Andersson JD, Wuest F, Spreckelmeyer S. Good practices for 68Ga radiopharmaceutical production. EJNMMI Radiopharm Chem 2022; 7 (01) 27
- 31 Wang IE, Morrissette LJ, Wong KK, Brooks AF, Dakanali M, Scott PJH. A comparison of routine [68Ga]Ga-PSMA-11 preparation using Locametz and Illuccix kits. EJNMMI Radiopharm Chem 2024; 9 (01) 87

